Related Experiment Video

Updated: Jun 24, 2026

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
08:38

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Published on: November 8, 2015

Response to Panteghini "About Analytical Performance Specifications for Immunosuppressive Drug Measurements"

Maria Shipkova1, Eberhard Wieland1, Ekkerhard Schütz2

  • 1Bioscientia Institut für Medizinische Diagnostik, Ingelheim, Germany; and.

Therapeutic Drug Monitoring
|June 22, 2026
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

Related Experiment Videos

Last Updated: Jun 24, 2026

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
08:38

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Published on: November 8, 2015

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

Related Concept Videos

Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...

Articles linked to this work by shared authors, journal, and citation graph.

First performance verification of automated cobas® i601 LC-MS/MS in a high-throughput clinical laboratory using 25-hydroxyvitamin D, 5α-dihydrotestosterone, and 17α-hydroxyprogesterone.

Clinical chemistry and laboratory medicine·2026

Improving diagnostic performance of kidney allograft rejection with a model combining relative fraction and absolute copies of donor-derived cell-free DNA-Results from 5 independent cohorts.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026

To Convert or Not to Convert? Official International Association of Therapeutic Drug Monitoring and Clinical Toxicology Guideline: Considerations and Recommendations for Converting Capillary Blood Microsampling Concentrations to Plasma Concentrations.

Therapeutic drug monitoring·2025

[Analysis of lipid levels in medical laboratories in Germany from 2017 to 2022 considering the impact of COVID-19 lockdown measures].

Wiener medizinische Wochenschrift (1946)·2025

Toward Analytical Performance Specifications for Immunosuppressive Drug Quantification in Transplantation: An Opinion Article.

Therapeutic drug monitoring·2024

Everolimus Personalized Therapy: Second Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology.

Therapeutic drug monitoring·2024

Exploring the Clinical Pharmacokinetics of Sitagliptin in Healthy and Diseased Populations: A Systematic Critical Review.

Therapeutic drug monitoring·2026

KCNA3 Gene Polymorphism Affects the Efficacy and Plasma Concentration of Perampanel in Patients With Refractory Epilepsy.

Therapeutic drug monitoring·2026

Early Tacrolimus Underexposure Predicts Acute Rejection After Renal Transplantation.

Therapeutic drug monitoring·2026

Optimizing Immunosuppressant Transition Strategies: Population Pharmacokinetic Analysis of Tacrolimus to Sirolimus Conversion in Renal Transplantation.

Therapeutic drug monitoring·2026

High-throughput UHPLC-MS/MS Assay for the Quantification of Venetoclax in Patients with Acute Myeloid Leukemia and Assessment of Clinical Application: A Short Communication.

Therapeutic drug monitoring·2026

A Retrospective Analysis of Itraconazole and Hydroxy-Itraconazole Serum Concentrations Correlation to Clinical Outcomes of Histoplasmosis Treatment.

Therapeutic drug monitoring·2026

Blood-brain barrier penetration and tissue distribution of the selective membrane progesterone receptor α (mPRα/PAQR7) agonist Org OD 02-0.

Frontiers in endocrinology·2026

Pharmacokinetic and Pharmacodynamic Bio-Similarity of ADL-018 to Innovator Omalizumab: A Randomized Study in Healthy Adults.

Clinical pharmacology in drug development·2026

The neurosteroid paradigm in perinatal depression: From pathophysiology to precision therapeutics.

Journal of neuroendocrinology·2026

In Vivo Real-Time Detection of Phenylephrine in Mice Using Boron-Doped Diamond Microelectrodes with Simultaneous Video-Based Assessment of Pupil Size.

ACS sensors·2026

Semaglutide Bioavailability: Limitations, Formulation Innovation and Future Opportunities.

Pharmaceutical research·2026

Considerations for the dynamic role of bile acids during oral drug discovery and development.

npj drug discovery·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us